Diclofenac, a popular painkiller sold as Voltaren and other brand names, is as risky as Vioxx and should be taken off the market, Canadian researchers warn. However, in the absence of action from ...

Current guidelines recommend that patients at risk for ulcer disease who require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are selective for cyclooxygenase-2 or ...

The painkiller diclofenac isn't very popular in the U.S., but it's by far the most widely used non-steroidal anti-inflammatory drug, or NSAID, in the world. A slew of studies, though, show diclofenac ...

Diclofenac, a common painkiller, has significant anti-cancer properties, according to researchers. Like other drugs examined by the ReDO project, diclofenac is cheap and readily accessible -- and as ...

The painkiller diclofenac, sold as Voltaren, should be pulled from the market, argue researchers from the UK and Canada, after finding it remains popular despite known cardiovascular risks. Scientists ...